Isomorphic Labs Chief Executive Officer Demis Hassabis stated that the $5 billion in new capital will accelerate the company's platform scale toward designing hundreds of drugs annually and moving into clinical trials
Agree
Disagree
Overview
Debates
Related claims
Topics
Sources
From the article
Isomorphic Labs raises $5bn from Sequoia and Greenoaks for AI drug design
Also in
Sequoia, Greenoaks Lead Isomorphic Lab’s $5 Billion Funding Round
4
41e85161
Article
Isomorphic Labs raises $5bn from Sequoia and Greenoaks for AI drug design
0
4
41e85161
Article
Sequoia, Greenoaks Lead Isomorphic Lab’s $5 Billion Funding Round
0
Opening sign-in…